Terms: = Breast cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
1080 results:
1. Unlocking the paracrine crosstalk: adipocyte-derived factors affect carbonic anhydrase IX expression in colon and breast cancer cells.
Lapinova J; Balaz M; Balazova L; Csaderova L; Golias T; Zatovicova M; Heeren J; Pastorekova S; Takacova M
Neoplasma; 2024 Apr; 71(2):164-179. PubMed ID: 38766857
[TBL] [Abstract] [Full Text] [Related]
2. Novel carbamodithioate regulates cellular hypoxia through chemical activation of prolyl hydroxylase-2 for breast cancer chemoprevention.
Rastogi S; Ansari MN; Saeedan AS; Yadav S; Kumar D; Singh SK; Mukerjee A; Singh M; Kaithwas G
Chem Biol Drug Des; 2024 May; 103(5):e14531. PubMed ID: 38726798
[TBL] [Abstract] [Full Text] [Related]
3. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing cancer Metastasis.
Tsai HE; Chen CL; Chang TT; Fu CW; Chen WC; Perez SJLP; Hsiao PW; Tai MH; Li WS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673867
[TBL] [Abstract] [Full Text] [Related]
4. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
[TBL] [Abstract] [Full Text] [Related]
5. The ras-related protein RAB22A interacts with hypoxia-inducible factor 1-alpha (HIF-1α) in MDA-MB-231 breast cancer cells in hypoxia.
Papanikolaou NA; Kakavoulia M; Ladias C; Papavassiliou AG
Mol Biol Rep; 2024 Apr; 51(1):564. PubMed ID: 38647725
[TBL] [Abstract] [Full Text] [Related]
6. Subcellular expression of MTA1, hif1a and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
[TBL] [Abstract] [Full Text] [Related]
7. [Metformin suppresses hypoxia-inducible factor-1
Shao S; Bai W; Zhou P; Luo M; Zhao X; Lei J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):428-436. PubMed ID: 38597433
[TBL] [Abstract] [Full Text] [Related]
8. Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.
Rastogi S; Ansari MN; Saeedan AS; Singh SK; Mukerjee A; Kaithwas G
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23679. PubMed ID: 38486411
[TBL] [Abstract] [Full Text] [Related]
9. Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.
Liu Y; Suhail Y; Novin A; Afzal J; Pant A; Kshitiz
Hum Cell; 2024 May; 37(3):768-781. PubMed ID: 38478356
[TBL] [Abstract] [Full Text] [Related]
10. Revealing Novel Source of breast cancer Inhibitors from Seagrass
Prajoko YW; Qhabibi FR; Gerardo TS; Kizzandy K; Tanjaya K; Willyanto SE; Permatasari HK; Surya R; Mayulu N; Taslim NA; Tjandrawinata RR; Syahputra RA; Tallei TE; Tsopmo A; Kim B; Kurniawan R; Nurkolis F
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474594
[No Abstract] [Full Text] [Related]
11. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, hif1a, and MYC genes in breast cancer.
Yousefi A; Sotoodehnejadnematalahi F; Nafissi N; Zeinali S; Azizi M
Sci Rep; 2024 Mar; 14(1):5845. PubMed ID: 38462658
[TBL] [Abstract] [Full Text] [Related]
12. Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution.
Kassis G; Palshikar MG; Hilchey SP; Zand MS; Thakar J
J Theor Biol; 2024 Apr; 583():111769. PubMed ID: 38423206
[TBL] [Abstract] [Full Text] [Related]
13. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
14. Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer.
Zhong J; Tang Y
Prog Biophys Mol Biol; 2024 May; 188():1-18. PubMed ID: 38387519
[TBL] [Abstract] [Full Text] [Related]
15. A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells.
Debnath J; Keshamasetthy D; Combs J; Leon K; Vullo D; Chatterjee A; McKenna R; Supuran CT
Bioorg Chem; 2024 Apr; 145():107192. PubMed ID: 38382393
[TBL] [Abstract] [Full Text] [Related]
16. Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer.
Zhuang JY; Huang ZN; Weng ZJ; Liu MM; Huang XQ; He D; Shao CK; Dong M
Breast Cancer; 2024 Mar; 31(2):317-328. PubMed ID: 38310620
[TBL] [Abstract] [Full Text] [Related]
17. A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
Chen L; Xu G; Song X; Zhang L; Chen C; Xiang G; Wang S; Zhang Z; Wu F; Yang X; Zhang L; Ma X; Yu J
Cancer Lett; 2024 Feb; 583():216635. PubMed ID: 38237887
[TBL] [Abstract] [Full Text] [Related]
18. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative breast cancer in Network Pharmacology.
Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
[TBL] [Abstract] [Full Text] [Related]
19. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
20. Should the breast cancer Staging System be Revised?
Sanli AN; Tekcan Sanli DE; Aydogan F; Altundag MK
Am Surg; 2024 May; 90(5):1066-1073. PubMed ID: 38128067
[TBL] [Abstract] [Full Text] [Related]
[Next]
